LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | – | 225 | -26.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 307 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 307 | -4.7% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 322 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -66.7% | 322 | -34.8% | 0.00% | – |
| Q3 2018 | $6,000 | +100.0% | 494 | +131.9% | 0.00% | – |
| Q2 2018 | $3,000 | +200.0% | 213 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 213 | +8.1% | 0.00% | – |
| Q4 2017 | $2,000 | -75.0% | 197 | -71.2% | 0.00% | – |
| Q3 2017 | $8,000 | -11.1% | 685 | +26.6% | 0.00% | – |
| Q2 2017 | $9,000 | -18.2% | 541 | -33.0% | 0.00% | – |
| Q1 2017 | $11,000 | +120.0% | 808 | +96.6% | 0.00% | – |
| Q4 2016 | $5,000 | -58.3% | 411 | -40.6% | 0.00% | – |
| Q3 2016 | $12,000 | +71.4% | 692 | +13.3% | 0.00% | – |
| Q2 2016 | $7,000 | – | 611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |